Zobrazeno 1 - 10
of 108
pro vyhledávání: '"H. Shabtai"'
Autor:
Tanya Gurevich, Glenn T. Stebbins, Xuehan Ren, Meir Kestenbaum, Nir Giladi, Tali Taichman, Aya Bar David, Talia Herman, Alina Rosenberg, Achinoam Faust-Socher, H. Shabtai, Christopher G. Goetz, Sheng Luo, Chava Peretz, Marina Brozgol, Pablo Martinez-Martin, Saar Anis, Adi Ezra
Publikováno v:
Neuroepidemiology. 54:356-362
Background: The Unified Dyskinesia Rating Scale (UDysRS) is a well-established tool for producing comprehensive assessments of severity and disability associated with dyskinesia in patients with Parkinson’s disease (PD). The scale was originally de
Autor:
Lihi Bar-Lev Schleider, Nir Giladi, Amos D. Korczyn, Judith Knaani, Yacov Balash, Ruth Djaldetti, H. Shabtai, Tanya Gurevich, Yehuda Baruch, Alina Rosenberg
Publikováno v:
Clinical Neuropharmacology. 40:268-272
Background The use of medical cannabis (MC) is controversial. Support for its benefits is based on small clinical series. Objective The aim of this study was to report the results of a standardized interview study that retrospectively assessed the ef
Autor:
Avner Thaler, Sheng Luo, Aya Ber David, Nir Giladi, Chava Peretz, H. Shabtai, Tanya Gurevich, Glenn T. Stebbins, Christopher G. Goetz, Jennifer Zitser, Marina Brozgol, Yuanyuan Liu, Barbara C. Tilley, Y. Balash, Meir Kestenbaum, Avi Gadoth, Talia Herman, Alina Rosenberg, Adi Ezra
Publikováno v:
Parkinsonismrelated disorders. 45
Background The Movement Disorders Society (MDS) published the English new Unified Parkinson's Disease Rating Scale (MDS-UPDRS) as the official benchmark scale for Parkinson's disease (PD) in 2008. We aimed to validate the Hebrew version of the MDS-UP
Publikováno v:
Acta Neurologica Scandinavica. 127:344-350
Balash Y, Mordechovich M, Shabtai H, Giladi N, Gurevich T,Korczyn AD. Subjective memory complaints in elders: depression,anxiety, or cognitive decline?Acta Neurol Scand: 2013: 127: 344–350.© 2012 John Wiley & Sons A/S.Objectives – To study the a
Publikováno v:
Acta Neurologica Scandinavica. 121:194-197
Balash Y, Mordechovich M, Shabtai H, Merims D, Giladi N. Subjective memory decline in healthy community-dwelling elders. What does this complain mean? Acta Neurol Scand: 2010: 121: 194–197. © 2009 The Authors Journal compilation © 2009 Blackwell
Autor:
Sabi H. Shabtai
The clock counts down to nuclear destruction in this “exciting” and “crackling good” thriller featuring infamous terrorist Carlos the Jackal (Publishers Weekly). Originally published in 1980, Five Minutes to Midnight remains of great interes
Publikováno v:
Movement Disorders. 21:1663-1666
The purpose of this study was to assess whether rivastigmine, a cholinergic agent, affects tremor features when given to improve cognition in demented Parkinson's disease (PD) patients. Demented PD patients (n = 26; Mini-Mental State Examination scor
Publikováno v:
Journal of Neural Transmission. 111:1447-1453
Background. It was commonly assumed that psychotic phenomena in Parkinson’s disease (PD) are mainly drug related. Accumulating evidence suggests the existence of other risk factors for psychosis in PD. Aims. To evaluate the contribution of the drug
Publikováno v:
Acta Neurologica Scandinavica. 107:252-255
Objectives – Quantitative electroencephalogram (qEEG) can be used to measure the effects of drugs on the brain. We studied the effects of rivastigmine on the qEEG in Parkinson's disease (PD) patients with dementia. Subjects and methods – Demented
Publikováno v:
Parkinsonism & Related Disorders. 8:243-246
Ninety-one consecutive patients with Parkinson's disease (PD) were asked to grade their general satisfaction from life (GSL) and completed the PDQ-39 and the quality of sexual life questionnaire (QoSL-Q). The reliability of the QoSL-Q was 0.74. Satis